THE FUTURE OF CELLULAR COMMUNICATION IN THE
HEALING
AND REGENERATION OF THE BODY
Featuring breakthrough technology in Exosomes derived from MSC Stem Cells.
Exosomes are the functional mechanism of the regenerative process provided by MSC Stem Cells.
This revolutionary MSC Exosomes regenerative medicine distributorship for clinical data purposes is the only one of its kind.
dG Medical Group holds the 100% master distribution contract for Exosome products. We partner with local Medical Research Institutions to perform innovative research on the regenerative properties of stem cell derived Exosomes and their contents. Together with our researchers, we are laying the foundation for the development of FDA-approved clinical exosome products.
Mesenchymal stem cells (MSCs) are multipotent cells that have the ability to differentiate into different cell types, such as bone cells, cartilage cells, fat cells, and muscle cells. Human umbilical cord mesenchymal stem cells (hUCMSCs) are a type of stem cell that possess immunomodulatory properties, meaning, among other things, that they can regulate the immune response.
hUCMSCs are considered advantageous compared to other sources of MSCs, such as bone marrow or adipose tissue, due to their non-invasive collection process and their abundant supply. The collection of hUCMSCs does not involve any harm to the mother or the baby, as they are typically obtained from the umbilical cord after the birth of a baby.
This ground-breaking research and technology is now available to you as a research drug status for clinical medical data collection purposes.
PRODUCTS:
Human Umbilical Cord Mesenchymal
Stem Cell Derived Exosomes
100 billion Exosomes | 40 billion Exosomes | 20 billion Exosomes
The use of exosomes represents a new frontier in regenerative health solutions. Regenerative medicine is an emerging field and little is known about this in the public sphere outside of the existing cutting-edge innovative research.
Exosomes are small extracellular vesicles that are released by various cells in the body. They play a role in intercellular communication and can carry bioactive molecules, such as proteins, nucleic acids, and lipids. In regenerative medicine. Exosomes are being investigated for their potential to promote tissue regeneration, modulate immune responses, and deliver therapeutic payloads to target cells.
Compared to stem cells, the exosome treatment is cell free and therefore represents a low-risk treatment compared to stem cells. Studies have shown that treatments with exosomes show similar or better results when compared to stem cell treatment. Based on this information, it is thought that stem cell treatment facilitates its beneficial effects through the secretion of exosomes rather than effects of the stem cells themselves. By using exosomes directly, we can eliminate the injection of stem cells which is known to cause potential issues during treatment.
Exosomes are the functional mechanism of the regenerative process provided by MSC Stem Cells. Due to the fact that dG Medical Group's Exosomes are a cell free product, they avoid the common risks associated with live cell biologics.
As with any emerging field of medicine, regulatory bodies and authorities have an important role in ensuring the safety and efficacy of exosome-based therapies. The FDA has recently notified the industry that all regenerative medicine products intended for clinical use must go through their regulatory process. dG Medical Group now has a Biologic Drug Masterfile for its MSC Exosomes. This landmark achievement makes it the only product legally permitted to be sold for clinical use through research.
DISTRIBUTORSHIP
dG Medical Group has recently obtained access to MSC Exosomes products developed by a University-based group & associated partners for distribution...
Quality
Our manufacturer of MSC Exosomes are third party tested to validate component concentrations.
Consistency
Our manufacturers processes and meticulous standards ensure product consistency every time!
Regulations
All of our products are rigorously tested through the same batch safety testing as used in the pharmaceutical industry.